CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
109.34
+2.27 (2.12%)
At close: Jul 28, 2026, 4:00 PM EDT
108.47
-0.87 (-0.80%)
After-hours: Jul 28, 2026, 7:50 PM EDT
CVS Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 407,905 | 402,067 | 372,809 | 357,776 | 322,467 | 292,111 | |
Revenue Growth | 7.64% | 7.85% | 4.20% | 10.95% | 10.39% | 8.71% |
Cost of Revenue | 351,315 | 346,705 | 321,408 | 303,345 | 267,965 | 239,991 |
Gross Profit | 56,590 | 55,362 | 51,401 | 54,431 | 54,502 | 52,120 |
Selling, General & Admin | 44,899 | 44,977 | 41,706 | 39,832 | 38,212 | 37,021 |
Other Operating Expenses | - | 5,725 | 1,179 | 158 | 3,270 | 1,789 |
Total Operating Expenses | 44,899 | 50,702 | 42,885 | 39,990 | 41,482 | 38,810 |
Operating Income | 5,966 | 4,660 | 8,516 | 13,743 | 7,954 | 13,310 |
Interest Expense | -1,582 | -3,119 | -2,958 | -2,658 | 2,287 | 2,503 |
Other Non-Operating Income (Expense) | 58 | 595 | 590 | 88 | -169 | -634 |
Total Non-Operating Income (Expense) | -1,524 | -2,524 | -2,368 | -2,570 | 2,118 | 1,869 |
Pretax Income | 3,457 | 2,136 | 6,148 | 11,173 | 5,836 | 10,537 |
Provision for Income Taxes | 554 | 408 | 1,562 | 2,805 | 1,509 | 2,548 |
Net Income | 2,903 | 1,728 | 4,586 | 8,368 | 4,327 | 7,989 |
Minority Interest in Earnings | 14 | -40 | -28 | 24 | 16 | -12 |
Net Income to Common | 2,932 | 1,768 | 4,614 | 8,344 | 4,311 | 8,001 |
Net Income Growth | -44.47% | -61.68% | -44.70% | 93.55% | -46.12% | 11.45% |
Shares Outstanding (Basic) | 1,270 | 1,267 | 1,259 | 1,285 | 1,312 | 1,319 |
Shares Outstanding (Diluted) | 1,274 | 1,271 | 1,262 | 1,290 | 1,323 | 1,329 |
Shares Change | 1.03% | 0.71% | -2.17% | -2.49% | -0.45% | 1.14% |
EPS (Basic) | 2.31 | 1.40 | 3.67 | 6.49 | 3.29 | 6.07 |
EPS (Diluted) | 2.27 | 1.39 | 3.66 | 6.47 | 3.26 | 6.02 |
EPS Growth | -45.82% | -62.02% | -43.43% | 98.47% | -45.85% | 10.05% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 7,394 | 7,807 | 6,326 | 10,395 | 13,450 | 15,745 |
Free Cash Flow Growth | 24.46% | 23.41% | -39.14% | -22.71% | -14.58% | 17.26% |
Free Cash Flow Per Share | 5.80 | 6.14 | 5.01 | 8.06 | 10.17 | 11.85 |
Dividends Per Share | 2.660 | 2.660 | 2.660 | 2.420 | 2.200 | 2.000 |
Dividend Growth | 0% | 0% | 9.92% | 10.00% | 10.00% | 0% |
Gross Margin | 13.87% | 13.77% | 13.79% | 15.21% | 16.90% | 17.84% |
Operating Margin | 1.46% | 1.16% | 2.28% | 3.84% | 2.47% | 4.56% |
Profit Margin | 0.71% | 0.43% | 1.23% | 2.34% | 1.34% | 2.73% |
FCF Margin | 1.81% | 1.94% | 1.70% | 2.91% | 4.17% | 5.39% |
EBITDA | 5,966 | 9,266 | 13,113 | 18,109 | 12,178 | 17,796 |
EBITDA Margin | 1.46% | 2.30% | 3.52% | 5.06% | 3.78% | 6.09% |
EBIT | 5,966 | 4,660 | 8,516 | 13,743 | 7,954 | 13,310 |
EBIT Margin | 1.46% | 1.16% | 2.28% | 3.84% | 2.47% | 4.56% |
Effective Tax Rate | 16.03% | 19.10% | 25.41% | 25.11% | 25.86% | 24.18% |